Seminars in Liver Disease

Papers
(The median citation count of Seminars in Liver Disease is 2. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
Insights into Nonalcoholic Fatty-Liver Disease Heterogeneity59
Effects of Mediterranean Diet in Patients with Nonalcoholic Fatty Liver Disease: A Systematic Review, Meta-Analysis, and Meta-Regression Analysis of Randomized Controlled Trials42
Management of Acute Liver Failure: Update 202240
Alagille Syndrome: A Focused Review on Clinical Features, Genetics, and Treatment39
Role of FXR in Bile Acid and Metabolic Homeostasis in NASH: Pathogenetic Concepts and Therapeutic Opportunities33
Hepatic Alveolar Echinococcosis32
Interleukin-17 in Liver Disease Pathogenesis31
Cellular Senescence in Liver Disease and Regeneration30
Aging and Chronic Liver Disease28
Early Diagnosis and Prevention of Infections in Cirrhosis24
Molecular Mechanisms of Hepatoblastoma23
The Role of Liver Zonation in Physiology, Regeneration, and Disease22
Nonalcoholic Fatty Liver Disease: Current Global Burden21
Role of Multidisciplinary Care in the Management of Hepatocellular Carcinoma20
Nonalcoholic Steatohepatitis Drug Development Pipeline: An Update20
Plasma Exchange in Acute and Acute on Chronic Liver Failure19
Adjuvant versus Neoadjuvant Immunotherapy for Hepatocellular Carcinoma: Clinical and Immunologic Perspectives17
A Global Systematic Review of Hepatitis C Elimination Efforts through Micro-Elimination17
Finite Antiviral Therapy in Chronic Hepatitis B Patients with Cirrhosis16
The Inside-Out of End-Stage Liver Disease: Hepatocytes are the Keystone16
Gut–Liver Axis in Nonalcoholic Fatty Liver Disease: the Impact of the Metagenome, End Products, and the Epithelial and Vascular Barriers15
Differential Roles for Diploid and Polyploid Hepatocytes in Acute and Chronic Liver Injury15
Management of Obesity and Nonalcoholic Fatty Liver Disease: A Literature Review15
Intrahepatic Cholestasis of Pregnancy: Natural History and Current Management15
Wearables, Physical Activity, and Exercise Testing in Liver Disease14
Deciphering Tumor Heterogeneity in Hepatocellular Carcinoma (HCC)—Multi-Omic and Singulomic Approaches14
Role of Lipogenesis Rewiring in Hepatocellular Carcinoma14
Shared Mechanisms between Cardiovascular Disease and NAFLD13
Scavenger Receptors: Novel Roles in the Pathogenesis of Liver Inflammation and Cancer13
Risks and Rewards of Bariatric Surgery in Advanced Chronic Liver Diseases13
The Current Status of Granulocyte-Colony Stimulating Factor to Treat Acute-on-Chronic Liver Failure13
Clinical Application and Progress of Fecal Microbiota Transplantation in Liver Diseases: A Review12
New Developments in Microbiome in Alcohol-Associated and Nonalcoholic Fatty Liver Disease12
Mechanisms of Pharmacoresistance in Hepatocellular Carcinoma: New Drugs but Old Problems11
Metabolic Injury of Hepatocytes Promotes Progression of NAFLD and AALD11
Combination Immunotherapy for Hepatocellular Carcinoma: Where Are We Currently?11
NAFLD in Cardiovascular Diseases: A Contributor or Comorbidity?11
Circadian Regulation of Gene Expression and Metabolism in the Liver10
Drug-Induced Vanishing Bile Duct Syndrome: From Pathogenesis to Diagnosis and Therapeutics10
Treating Alcohol Use Disorder in Patients with Alcohol-Associated Liver Disease: Controversies in Pharmacological Therapy10
The Changing Epidemiology of Alcohol-Associated Liver Disease: Gender, Race, and Risk Factors10
Organoids for the Study of Liver Cancer10
Role of YAP1 Signaling in Biliary Development, Repair, and Disease9
The Neglected Role of Bile Duct Epithelial Cells in NASH9
Noninvasive Algorithms for the Case Finding of “At-Risk” Patients with NAFLD8
Growth Hormone Signaling in Liver Diseases: Therapeutic Potentials and Controversies8
Application of Risk Scores for Hepatocellular Carcinoma in Patients with Chronic Hepatitis B: Current Status and Future Perspective8
The Key Role of Staging Definitions for Assessment of Downstaging for Hepatocellular Carcinoma8
Dietary Treatment for NAFLD: New Clinical and Epidemiological Evidence and Updated Recommendations8
Insights into the Role of Granulocyte Colony-Stimulating Factor in Severe Alcoholic Hepatitis8
Management of Portal Vein Thrombosis in Cirrhosis8
MRGPRX4 in Cholestatic Pruritus7
Fontan-Associated Liver Disease: Pathophysiology, Staging, and Management7
Biomarker Development Using Liquid Biopsy in Hepatocellular Carcinoma7
HNF4α in Hepatocyte Health and Disease7
Toward a Liver Cell Atlas: Understanding Liver Biology in Health and Disease at Single-Cell Resolution7
Novel Biomarkers of AKI in Cirrhosis7
Regulation of Progression and Resolution of Liver Fibrosis by Immune Cells7
Three-Dimensional Organoids as a Model to Study Nonalcoholic Fatty Liver Disease7
Liver Transplantation Selection and Allocation Criteria for Hepatocellular Carcinoma: A European Perspective7
Mesenchymal Stem Cell Transplantation in Liver Diseases6
Genetic Contributions to Biliary Atresia: A Developmental Cholangiopathy6
Liver Immunology, Immunotherapy, and Liver Cancers: Time for a Rethink?6
Gut Microbiome-Centered Therapies for Alcohol-Associated Liver Disease6
Intestinal Barrier Dysfunction in Fatty Liver Disease: Roles of Microbiota, Mucosal Immune System, and Bile Acids5
Recurrent Primary Sclerosing Cholangitis: Current Understanding, Management, and Future Directions5
Bioengineered Liver Models for Investigating Disease Pathogenesis and Regenerative Medicine5
To TIPS or Not to TIPS in High Risk of Variceal Rebleeding and Acute-on-Chronic Liver Failure5
Mechanisms of Lipid Droplet Accumulation in Steatotic Liver Diseases5
Hepatitis B Core-Related Antigen: From Virology to Clinical Application5
Therapeutic Pipeline in Alcohol-Associated Liver Disease5
Liver Imaging Reporting and Data System: Review of Pros and Cons5
Hepatitis Delta Infection: A Clinical Review5
Novel Mechanisms for Resolution of Liver Inflammation: Therapeutic Implications4
Cell Therapy for Liver Disease: From Promise to Reality4
Cellular Homeostasis and Repair in the Biliary Tree4
The Ploidy State as a Determinant of Hepatocyte Proliferation4
Endoscopic Advances in Hepatology4
Dietary Recommendations for the Management of Non-alcoholic Fatty Liver Disease (NAFLD): A Nutritional Geometry Perspective4
Nonalcoholic Fatty Liver Disease and Cardiovascular Disease: Overlapping Mechanisms4
Hepatocellular Carcinoma Chemoprevention with Generic Agents4
Unraveling the Complexity of Liver Disease One Cell at a Time4
Cirrhosis Management in the Intensive Care Unit3
Role of Biliary Organoids in Cholestasis Research and Regenerative Medicine3
Hedgehog Signaling: Implications in Liver Pathophysiology3
Beyond Varices: Complications of Cirrhotic Portal Hypertension in Pediatrics3
Mast Cell and Innate Immune Cell Communication in Cholestatic Liver Disease2
Update on Hepatobiliary Plasticity2
Critical Care Management of Acute-on-Chronic Liver Failure: Certainties and Unknowns2
Early Implementation of Palliative and Supportive Care in Hepatocellular Carcinoma2
The Mechanism of Interleukin-35 in Chronic Hepatitis B2
Pediatric and Adult Liver Disease in Alpha-1 Antitrypsin Deficiency2
Biliary Tract Cancer: Molecular Biology of Precursor Lesions2
Surrogate Markers for Hepatitis B Virus Covalently Closed Circular DNA2
New Nomenclature for Nonalcoholic Fatty Liver Disease: Understanding Metabolic Dysfunction-Associated Steatotic Liver Disease, Metabolic Dysfunction- and Alcohol-Associated Liver Disease, and Their Im2
Recent Advances in Intrahepatic Biliary Epithelial Heterogeneity2
Angiocrine Signaling in Sinusoidal Health and Disease2
Novel Antidiabetic Strategies and Diabetologists' Views in Nonalcoholic Steatohepatitis2
Assessing Toxicity in Drug Trials in Liver Disease2
Management of Multidrug-Resistant Infections in Cirrhosis2
Post-Transplant Biliary Strictures: An Updated Review2
Current Challenges and Future Direction in Surveillance for Hepatocellular Carcinoma in Patients with Nonalcoholic Fatty Liver Disease2
FXR Friend-ChIPs in the Enterohepatic System2
Involvement of Epigenomic Factors in Bile Duct Cancer2
GAS6/TAM Axis as Therapeutic Target in Liver Diseases2
Emerging Links between Nonalcoholic Fatty Liver Disease and Neurodegeneration2
0.031044006347656